Indiana to receive $16.5M in national opioid settlement involving eight drugmakers. AG Rokita proud of efforts to hold responsible parties accountable.

A recently launched video series from the Biotechnology Innovation Organization (BIO) seeks to show how biotech may be able ...

Indiana Attorney General Todd Rokita has secured $720 million in settlements with eight drug makers that manufacture opioid pills, with Indiana expected to receive $16.5 million, to hold accountable ...

Aurobindo, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir. Aurobindo, Cipla and ...

Attorney General Todd Rokita announced Monday that Indiana is expected to receive $16.5 million as part of a multi-state ...

Viatris in Egypt, a part of global healthcare company Viatris, announced the launch of Norvasc Val, a combination therapy for ...

DUSA offers a high conviction, value-focused approach with a concentrated portfolio. Learn more about DUSA ETF and my ...

A federal court ruled in Mylan's favor, finding no infringement of Novo's patent tied to Wegovy, rejecting direct, ...

After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic ...

LAVAL, QC / ACCESS Newswire / July 24, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, today announced the appointment of Michael Goettler and Sa ...

The Delaware court ruled that Viatris’ drug does not infringe the "administered without another therapeutic agent" limitation ...

Commercial stage pharmaceutical firm Shield Therapeutics, which has a base in Gateshead, is on track to become cash flow positive by the end of this year, following a strong Q2 ...